Status:
COMPLETED
Chemotherapy Treatment for Children With Intraocular Germ-Line Retinoblastoma
Lead Sponsor:
Ann & Robert H Lurie Children's Hospital of Chicago
Conditions:
Retinoblastoma
Retinal Neoplasms
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
Retinoblastoma is an unusual cancer of early childhood involving tumor is both eyes or, in certain circumstances, one eye only. This condition is the result of an abnormal gene which makes both retina...
Eligibility Criteria
Inclusion
- Eligibility Criteria:
- Initial clinical diagnosis of Retinoblastoma, with Bilateral tumors, OR Unilateral tumor with hope for salvage of vision AND Multiple primary tumors, or positive family history for retinoblastoma, or age \< 12 months
- No prior antitumor therapy (except enucleation of one eye)
- At least one tumor exceeds 6 mm in diameter
- No evidence of dissemination outside the globe
- Signed IRB-approved informed consent
- Patient/family available for follow-up
Exclusion
Key Trial Info
Start Date :
April 1 1996
Trial Type :
INTERVENTIONAL
End Date :
September 1 2006
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00179920
Start Date
April 1 1996
End Date
September 1 2006
Last Update
August 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Memorial Hospital
Chicago, Illinois, United States, 60614